Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04100694
Brief Title: Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

First Submitted : September 20, 2019
First Submitted that Met QC Criteria : September 20, 2019
First Posted : September 24, 2019

Last Update Submitted that Met QC Criteria : September 20, 2019
Last Update Posted : September 24, 2019